US Congressman Welcomes India’s Decision to Resume Export of Surplus Covid Vaccine
An influential member of the US Congress hailed India’s decision to resume exporting surplus COVID-19 vaccines to meet its commitment to the global COVAX pool.
Indian Health Minister Mansukh Mandaviya said on Monday that the country will resume COVID-19 surplus vaccine exports in the fourth quarter of this year under the ‘Vaccine Maitri’ program to meet its commitment to the global COVAX pool . He said, however, that vaccinating his own citizens remains the government’s top priority. COVAX is co-led by Gavi, the Coalition for Epidemic Preparedness Innovations and the WHO.
“I welcome today’s announcement by the Indian government to resume exports of COVID-19 vaccines,” Congressman Gregory Meeks, chairman of the powerful House of Representatives foreign affairs committee, said on Monday in a tweet.
“As the world’s largest vaccine maker, India’s role is critical in beating this pandemic,” Meeks tweeted, tagging a New York Times article. India had halted the export of COVID-19 vaccines after the second wave of the COVID-19 pandemic hit the country in April this year.